The globalPharmacovigilance (PV) marketsize was USD 6.97 Billion in 2021 and is expected to register a revenue CAGR of 10.5% during the forecast period, according to latest analysis by Emergen Research. Increasing outsourcing of pharmacovigilance is a major factor driving market revenue growth. Small-scale biotech and pharmaceutical companies have a few internal resources with expertise in safety. Modern PV applications make it simple for businesses to outsource safety services without sacrificing control or data visibility. In addition, cloud technologies drive greater collaboration and transparency for improved coordination and communication between pharmaceutical companies and service providers or Clinical Research Organizations (CROs).
This report is the latest document encompassing the massive changes that took place in the Pharmacovigilance market following the emergence of the COVID-19 pandemic. The pandemic has drastically affected the global economic landscape, thereby disrupting the operating mechanism of the Pharmacovigilance market. The severe global crisis has prompted organizations to efficiently respond to the rapidly shifting business environment.
To get a sample copy of the global Graphene market report, visit @https://www.emergenresearch.com/request-sample/81
Pharmacovigilance MarketCompetitive Terrain:
The global Pharmacovigilance market is highly consolidated due to the presence of numerous companies operating across this industry. The report depicts the current market standing of these companies, their past performances, demand and supply graphs, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market. The leading market contenders listed in the report are:ArisGlobal, Accenture, Cognizant, Capgemini, IBM Corporation, IQVIA, BoClinica Inc., Laboratory Corporation of America Holdings, Linical Accelovance, and ITClinical, among others.
PharmacovigilanceMarket Segmentation:
Emergen Research has segmented the global pharmacovigilance on the basis of type, service provider, clinical trial phase, end-users, and region:
TypeOutlook (Revenue, USD Million; 2017-2027)
Spontaneous Reporting
Intensified Adverse Drug Reaction (ADR) Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
Electronic Health Record (HER) Mining
Service ProviderOutlook (Revenue, USD Million; 2017-2027)
In-House
Contract Outsourcing
Clinical Trial PhaseOutlook (Revenue, USD Million; 2017-2027)
Pre-Clinical
Phase I
Phase II
Phase III
Phase IV
End-UsersOutlook (Revenue, USD Million; 2017-2027)
Hospitals
Research Organizations
Others
To get the report at an incredible discount, visit @https://www.emergenresearch.com/request-discount/81
PharmacovigilanceMarket Key Highlights
In December 2019, UCB and Accenture made an announcement about signing of a partnership agreement to build a safety solution on INTIENT pharmacovigilance, by Accenture, to accelerate patient safety case reports processing. The agreement is intended to help UCB in discovering the influence of existing treatments on patients safety and therefore managing the novel drugs risk in a better way.
Spontaneous reporting is a crucial type in pharmacovigilance by providing information from real clinical settings in the course of a drugs life. Physicians and many other healthcare specialists contribute immensely to improving public health by supposed adverse drug reactions reporting.
Several firms support in-house reporting management to healthcare authorities, as in-house reporting is possibly the major contact entity for any kind of in and out deliberation.
The escalating sophistication of biologics therapeutic agents and the growing deployment of novel agents makes it essential to identify any undesired and unforeseen adverse events and other toxicities as early as possible. Popular instances associated with the withdrawal of a drug from the market after receiving sanction, verify Phase IV pharmacovigilance requirement.
Major Geographies Analyzed in the Report:
North America(U.S., Canada)
Europe(U.K., Italy, Germany, France, Rest of EU)
Asia-Pacific(India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America(Chile, Brazil, Argentina, Rest of Latin America)
In conclusion, the report provides a qualitative and quantitative analysis of the Global Pharmacovigilance market, including the global and regional analysis of the market. The study covers critical information and factual data about the Pharmacovigilance market industry, along with an in-depth statistical analysis of the market drivers, limitations, growth prospects, opportunities, and threats. On the basis of the current market scope, the report provides an extensive analysis of how the Pharmacovigilance market is expected to fare in the forecast timeline. The report utilizes Pharmacovigilance analytical tools to offer an estimation of the outlook of the global state of the Pharmacovigilance market industry.
Request a customized copy of report @https://www.emergenresearch.com/request-for-customization/81
Thank you for reading our report. For further details or to inquire about the customization of the report, please reach out to our team. We will offer you the report as per your requirements.
Take a Look at our Related Reports:
Non fungible Token Markethttps://www.digitaljournal.com/pr/non-fungible-token-market-to-reach-130-35-billion-by-2030-at-10-7-cagr-emergen-research
Conditioning Markethttps://www.digitaljournal.com/pr/with-a-cagr-of-5-9-global-air-conditioning-market-is-expected-to-reach-usd-211-77-billion-in-2030-exclusive-report-by-emergen-research
Digital Water Markethttps://www.digitaljournal.com/pr/digital-water-market-to-observer-firm-development-throughout-2020-2028
Cancer Immunotherapy Markethttps://www.digitaljournal.com/pr/cancer-immunotherapy-market-to-hit-153-03-billion-by-2027-emergen-research
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web:www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail:sales@emergenresearch.com
Visit for More Insights:https://www.emergenresearch.com/insights
Explore OurCustom Intelligence services|Growth Consulting
Read Press Release@https://www.emergenresearch.com/press-release/global-pharmacovigilance-market
Latest ReportsNo-Code Development Platforms MarketFood Enzymes Market
Trending ReportsGraphene MarketHuman Capital Management Market
